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Understanding how to maintain independence and prevent disability in older persons 
represents a priority in aging research. Although undernutrition is considered as a 
putative and potentially modifiable factor contributing to decline in physical function 
with aging, there is a lack of empirical evidence of its effect on consequent decline in 
muscle strength and physical function. Furthermore, whether physiological factors 
such as ghrelin, leptin and inflammatory markers may affect dietary intake in older 
persons is unknown. The aim of this dissertation was to address this gap in knowledge 
by examining the following hypotheses: 1) a low intake of protein is associated with 
subsequent reduction in muscle strength; 2) a low concentration of nutrients is 
associated with subsequent decline in physical function; 3) concentrations of ghrelin, 
leptin, and inflammatory markers are associated with reduced dietary intake. To test 
these hypotheses, we used a population-based, NIH-funded epidemiological study 
involving over 1100 persons aged >65 years living in Tuscany, Italy.  
We found that selectively in participants with high levels of C-reactive protein, 
Interleukin-6 and Tumor Necrosis Factor-α, lower protein intake was associated with a 
greater decline in muscle strength (Beta for CRP=0.020, p=0.003). Furthermore, we 
demonstrated that a low concentration of vitamin E was significantly associated with 
subsequent decline in physical function (odds ratio=1.62; 95% confidence 
interval=1.11-2.36; p=0.01). A classification and regression tree analysis showed that 
among persons aged 70 to 80 years, the strongest predictor of decline in physical 
  
function was a vitamin E concentration < 32 umol/L (p=60%). Finally, we found that a 
high concentration of leptin was significantly associated with accelerated decline in 
energy intake (Beta=-38.0 kcal; p=0.039), and the effect of inflammatory markers on 
energy intake depended on sex (Beta for CRP(log)*sex=70.0, p=.020). 
This is the first population-based, longitudinal study on the effect of poor 
nutrition on decline in muscle strength and physical function, and on the effect of 
ghrelin, leptin, and inflammatory markers on dietary intake. This study provides 
empirical evidence that poor nutrition plays an important role in the decline in muscle 
strength and physical function in older persons and, consequently, may contribute to 
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In 2003, about 15% of Europeans and 12% of Americans were aged 65 years or older. 
The European and American States with the highest proportion of older persons were 
Italy (19%) and Florida (17%). The worldwide population aged >65 years is projected 
to increase by approximately 400 million from 2001 to 2030 (He W), increasing from 
15.5% to 24.3% in Europe, from 12.6% to 20.3% in North America, and from 6.0% to 
12.0% in Asia. Since the health care cost per capita is 3-5 times greater for persons 
aged 65 years and older than for younger persons (Jacobzone S), this demographical 
transition will result in a substantial increase in aging-related health problems and 
consequently health-related costs (Jacobzone S 2000). 
  Disability is one of the main public health concerns related to the aging 
population. Although the prevalence of disability declined from 1982 to 2004 (Manton 
KG 2006), the absolute number of disabled older persons is projected to increase as 
the population ages over the next two decades (Census Bureau 2000), with consequent 
burden for the individual who needs assistance, for caregivers who provide formal or 
informal help, and for increased level of health care utilization and, in turn, health-
related costs (Guralnik JM 2002). Thus, the prevention of disability and the 
maintenance of independence in older persons represent a priority in aging research.  
 The reduction of muscle strength that occurs with aging, named sarcopenia, is 
associated with reduced physical activity (Vandervoot AA 2001) and is considered 
one of the risk factors for the decline in physical function and the development of 
disability (Volpi E, Nazemi R 2004). The decline of physical function is associated 
with increased risk of other adverse health outcomes, including further declines in 
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function (Manton, 1988), falls (Tinetti et al. 1988; Nevitt et al. 1989), recurrent 
hospitalization (Koyano et al., 1986; Manton, 1988), disability (Guralnik 1995) with 
consequent dependence on formal and informal care providers. Thus, it is evident that 
sarcopenia and the reduction in physical function may strongly affect quality of life of 
older persons and result in substantial increase in medical and long-term care costs 
(Miller EA 2000). Consequently, understanding the mechanisms underlying these 
adverse outcomes has been identified as a high priority in the aging-related research 
agenda (Landefeld CS 1998; Ebrahim S 1999; Jette AM 1999). In particular, the 
identification of treatable risk factors represents a crucial step to prevent or reduce 
their potentially catastrophic consequences, and may substantially contribute to reduce 
health-related costs and to improve well-being in older persons.       
 Poor nutrition is considered as a putative and potentially modifiable factor 
contributing to decline in muscle strength and physical function. In particular, protein 
intake is the major factor responsible for muscle protein anabolism in older persons 
(Volpi E 2003). Thus, an adequate intake of protein is necessary to tip the balance 
between protein synthesis and degradation in favour of protein synthesis (Bennet et al. 
1989), and is considered to play a crucial role in maintaining muscle strength. In fact, 
increased intake of protein has been suggested as one of the potential strategies for 
reducing the decline of muscle strength that occurs with aging (Evans 1992, Roberts 
1995, Campbell 2001). Although results on protein supplementation have been 
inconsistent (Fiatarone 1994, Campbell 1995, Welle 1998, Bunout 2001), some 
studies strongly support this hypothesis. Schurch et al. (1998) conducted a 
randomized, double-blind, placebo-controlled trial and demonstrated that protein 
supplementation administered to patients with recent hip fracture improved clinical 
outcomes and muscle strength. Furthermore, Scognamiglio et al. (2005) showed that 
  3
protein supplementation in older persons with reduced physical activity significantly 
increased muscle strength after three months of treatment.  
These findings strongly suggest that protein intake plays an important role in 
sarcopenia. It is important to take into consideration, however, that these studies were 
on the effect of protein supplementation and not of dietary protein intake. Thus, the 
interpretation of the results may be complicated by a number of factors. In particular, 
the dose of protein and amino acids that likely ranges from physiological to mega 
doses, the characteristics of the group that has been targeted for supplementation, and 
the fact that older adults tend to reduce dietary intake during use of supplements 
(Volpi 2003) makes it difficult to conclude that protein intake derived from habitual 
food consumption may play an important role in sarcopenia in the general older 
population.  
In a previous study, we found that a low dietary intake of protein was 
associated with low muscle strength in a population-based study of community-living 
older persons (Bartali 2006). The cross-sectional design of this study, however, makes 
it impossible to establish whether dietary protein intake has an effect on subsequent 
decline in muscle strength. Consequently, population-based, longitudinal studies of 
older persons living in the community are urgently needed to address this gap in 
knowledge. In fact, the current Recommended Dietary Allowance (RDA) (Food and 
Nutrition Board 2001) for protein was derived from studies on nitrogen balance 
conducted in young men (Scrimshaw NS 1972), and whether this recommendation is 
adequate for the maintenance of muscle strength in older persons is unknown. 
Furthermore, in studying the effect of protein intake on muscle strength, it is important 
to consider that aging is characterized by physiological changes, such as increased 
concentrations of pro-inflammatory markers (Johnson TE 2006), that may alter protein 
metabolism and utilization. In fact, a pro-inflammatory state stimulates muscle protein 
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turnover (Volpi E 2003) and depresses net rates of protein synthesis (McNurlan MA 
2000, Volpi E, Roubenoff 1997). Thus, the effect of pro-inflammatory state that 
characterizes the aging process and is associated with muscle wasting and catabolism 
needs to be taken into consideration to understand the effect of protein intake on 
muscle strength in this particular segment of the population.   
Another important gap in knowledge is the effect of concentrations of nutrients 
on decline in physical function. Most of the studies available that consider nutrition as 
a factor in the pathogenesis of decline in physical function use weight loss as a proxy 
measure of undernutrition (Andreas E 1999, Ferrucci 2004). Weigh loss especially in 
the older population, however, may be caused by different factors such as the presence 
of diseases that increases catabolism (Roubenoff 1997). Thus, weight loss may not be 
an appropriate indicator of undernutrition in older persons. Previous studies suggested 
that concentrations of nutrients may play a role in reduction in physical function 
through different mechanisms. Antioxidants may play a preventive role in muscle 
damage by reducing oxidative injury (Clarkson 2000, Fano 2001) with subsequent 
muscle or neuronal cell damage (Mecocci P 1999, Coyle JT 1993) and decline in 
physical and cognitive function (Cesari 2004, Lu T 2004). In the InCHIANTI study, 
we found that low dietary intake of carotenoids and vitamin E was associated with low 
physical function (Cesari 2004). Vitamin E deficiency may increase oxidative stress 
(Clarkson PM 2000) and, consequently, may cause muscle damage (Mecocci 1999) 
and wasting (Moylan JS 2007). A deficiency of folate may cause abnormal cell 
replication, particularly in the erythropoietic system, leading to megaloblastic anemia 
(Wickramasinghe SN 2006). This type of anemia is caused also by the B12 deficiency 
(Wickramasinghe SN 2006) and may result in symptoms such as fatigue, weakness, 
and dementia (Goodman KI 1990; Stabler SP 2004; Dharmarajan TS 2003). Iron is the 
key element required for the delivery of oxygen to tissue. Iron-deficient workers with 
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the lowest hemoglobin concentrations had the shortest time to exhaustion (Gardner 
1977) and in iron-deficient anemic women, iron supplementation increased work 
capacity and reduced hearth rate and lactate concentration (Gardner 1975).  
Despite this strong theoretical basis, there is relatively little empirical evidence 
linking poor nutrition to decline in physical function. Previous studies (Snowdon 
DA1996) and our recent findings (Cesari 2004, Bartali 2006, Semba 2006, Bartali 
2006) have shown that poor nutrition is associated with reduced physical function, 
frailty and disability in older persons. These studies, however, have been limited by 
their cross-sectional design (Snodow DA 1996, Cesari 2004, Bartali 2006) or 
nonrepresentative samples, including, for example, only older women with some level 
of difficulty in physical function (Bartali 2006, Semba 2006). Thus, there is a lack of 
empirical evidence on the effect of undernutrition on consequent decline in physical 
function in older persons. This information could open a potential avenue for the 
development of strategies aimed at preventing the decline in physical function and 
disability in older persons, with an important impact on public-health costs and quality 
of life of older persons and their families.  
Given the potential detrimental effect of undernutrition on decline in muscle 
strength and physical function, another important question to address is whether 
physiological changes that occur with aging may affect dietary intake. Undernutrition 
has been identified as one of the “10 hot topics” in aging research (Morley 2004) and 
the term “anorexia of aging” has been coined to describe the physiologic decline in 
food intake that occurs with aging (Morley 2001, Morley 1997), predisposing to the 
development of undernutrition (Morley 1997). A large proportion of older adults 
living in the community have a deficient intake of nutrients according to the 
Recommended Dietary Allowance (Bartali 2003, Lee JS 2001). Although the 
pathogenesis of anorexia of aging is not well understood, it is clear that multiple 
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factors characterizing the aging process may contribute to its exacerbation, including 
psychological (e.g. cognitive function and depression), behavioral (e.g. physical 
activity and smoking), socio-economic (e.g. social network and economic status), 
pathologic (e.g. chronic diseases, use of medications, chewing problems) (Rolls BJ 
1992; Casper RC 1995; Elsner RJ 2002; Donini LM 2003) factors. 
Changes with aging in physiological factors, such as concentrations of specific 
hormones and markers of inflammation, are considered putative factors contributing to 
anorexia of aging (Morley 1997; Donini 2003). Ghrelin was recently identified by 
Kojima et al. (Kojima 1999) as an orexigenic hormone secreted primarily by the 
stomach and duodenum. It stimulates growth hormone secretion and increases food 
intake in rodents and humans by influencing mealtime-related appetite and hunger, 
and it has been suggested that defective ghrelin signaling contributes to energy 
unbalance (Inui 2004). Leptin inhibits food intake and stimulates energy expenditure 
by altering the transcription of specific hypothalamic neuropeptides such as the 
orexigenic peptides NPY (Kotz C 1998). Aging is associated with increased 
concentrations of inflammatory markers (Johnson TE 2006) that have been suggested 
to affect the sense of appetite in older persons (Morley 2007; Donini 2003). 
Supporting this hypothesis, in a randomized controlled trial conducted in cachectic 
geriatric patients, Yeh et al. (2000) found that the administration of megestrol acetate 
improved appetite, probably through a downregulation of cytokine synthesis and 
release. The effect of specific hormones and markers of inflammation on dietary 
intake in older persons, however, is unclear.  
In conclusion, the aim of this dissertation was to test the following hypotheses: 
1) a low intake of protein is associated with subsequent reduction in muscle strength 
(sarcopenia) and the effect of protein intake on muscle strength depends on 
concentrations of markers of inflammation; 2) a low concentration of nutrients is 
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associated with subsequent decline in physical function; 3) concentrations of ghrelin, 
leptin and inflammatory markers are associated with reduced dietary intake. 
To test these hypotheses, I will use the InCHIANTI Study, a population-based, 
NIH-funded epidemiological study designed to identify the risk factors contributing to 
decline in physical function in older persons. This study involves over 1100 men and 
women aged 65 years or older living in Tuscany, Italy. Given its strong focus on 
muscle strength and physical function, and the comprehensive assessment of dietary 
intake and levels of nutrients, hormones and inflammatory markers, InCHIANTI is 
particularly well suited to study the questions posed in this dissertation. InCHIANTI is 
an Italian population-based sample, raising potential concerns about the 
generalizability of the findings. It is unlikely, however, that the basic biological 
mechanisms underlying decline in muscle strength and physical function and in 
dietary intake with aging differ substantially from one country to another. 
Furthermore, the percentage of participants in this study who used nutritional 
supplements was very low (4%), in contrast to the United States (Murphy SP 2007). 
Thus, this study provides the opportunity to evaluate the “pure effect” of poor 
nutrition on the decline in physical function.  
To examine the effect of two hormones (ghrelin and leptin) on energy intake 
was one of the aims of this dissertation. Future studies, however, are needed to 
understand the mechanisms by which ghrelin, leptin and inflammatory markers may 
affect dietary intake. Furthermore, other circulating factors may play a crucial role in 
regulating dietary intake. In particular, the hypothalamus produces both orexigenic 
(such as neuropeptide Y) and anorectic peptides (such as alpha-melanocyte-
stimulating hormone). These peptides, however, were not measured in InCHIANTI. 
Thus, further studies are needed to understand the physiological changes that occur 
with advanced age, as well as the relationship and interaction among different 
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hormones regulating dietary intake.  
Furthermore, vitamin E was the only antioxidant I could use in this study. 
Thus, future studies including different antioxidants may help to understand whether 
other antioxidants would yield to the same results. It has been suggested that the 
antioxidant capacity of different compounds depends on several factors including the 
antioxidant-radical reactivity and interaction among antioxidants (Tsuchihashi, H 
1995). In fact, specific non-enzymatic antioxidants such as vitamins E, C and 
carotenoids may interact during their recycling mechanisms (Packer JE 1979; 
Freisleben HJ 1993; Niki E 1995), and the resulting synergistic effect has a better 
antioxidant capacity than the sum of the effect of each antioxidant (Niki E 1997). 
Consequently, future studies are needed to verify whether a synergistic effect exists 
among different antioxidants/nutrients on the decline of physical function. In addition, 
whether the effect of low levels of nutrients in decline in physical function is mediated 
by decline in muscle strength needs to be evaluated. Furthermore, future studies are 
needed to understand the mechanisms by which low intake/level of nutrients may lead 
to reduction in muscle strength/physical function. In particular, oxidative stress that 
results from an excessive production of reactive oxygen species (ROS) may play a 
central role in this pathway. Figure 1 shows the general conceptual model of my 
dissertation.  
The results of this study will address important and emerging gaps in our 
knowledge of the role of undernutrition on sarcopenia and physical function and in the 
identification of physiological changes that occur with aging that may contribute to 
undernutrition in this particular segment of the population. In turn, this study will help 
the development of screening and intervention strategies aimed at preventing 
undernutrition and the decline in muscle strength and in physical function, and 
subsequently disability, in older persons. Factors such as nutrition are particularly 
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desirable to study: they are generally modifiable and amenable to intervention, and are 
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Effect of Protein Intake on Change in Muscle Strength in Older Persons: 
Does Inflammation Matter? 
 
The decline of muscle mass and strength that occurs with advanced age, termed 
sarcopenia (Evans WJ 2001), is a major risk factor for the development of frailty and 
disability, and predicts hospitalization and mortality in older persons [Fried LP 2001; 
Ferrucci L 2004; Rantanen T 1999; Penninx BW 2000; Rantanen T 2003). The 
etiology of sarcopenia is unclear, but poor nutrition and responsiveness to nutrients are 
potential factors contributing to its development and progression (Volpi E 2004).  
In previous studies, we found that low protein intake was associated with 
frailty (Bartali B 2006), and that a low concentration of specific micronutrients was a 
predictor of disability (Bartali B 2006) in older persons living in the community. 
Although protein intake is primarily responsible for protein muscle anabolism in the 
older population (Volpi E 2003), its effect on muscle strength is unclear. The current 
Recommended Dietary Allowance (RDA) (Food and Nutrition Board 2001) for 
protein was derived from studies on nitrogen balance conducted in young men 
(Scrimshaw NS 1972), and whether this recommendation is adequate for the 
maintenance of physical function in older persons is unknown.  
This study was aimed at addressing this gap in knowledge by providing 
empirical evidence on the effect of protein intake on muscle strength, using a 
longitudinal study of older persons living in the community. Since high concentrations 
of markers of inflammation are associated with increased muscle wasting and protein 
catabolism (Volpi E 2003), we also examined whether the effect of protein intake on 




InCHIANTI (Invecchiare in Chianti, aging in the Chianti area) is a study of risk 
factors contributing to the decline of mobility in late life, conducted in two 
municipalities adjacent to the city of Florence (Italy). InCHIANTI has been described 
in detail elsewhere (Ferrucci L 2000). In brief, 1299 participants aged 65 years or 
more were randomly selected from the population registry. Of the 1260 participants 
who were eligible (39 had died or moved away from the area), 1155 (91.6%) 
participated in the study. After excluding those with disability at baseline (n=116), 
those with missing information on knee muscle strength at baseline (n=158) or at 
follow-up (156), and those who refused (n=71), emigrated (n=10), or died (n=46) 
during the three-year follow-up, the final analytical sample included 598 persons.  
Trained interviewers administered two structured questionnaires at the 
participant’s home: 1) a questionnaire to collect information on education, socio-
economical status, household composition, physical activity, functional and health 
status; and 2) a detailed food frequency questionnaire to collect data on dietary intake. 
Medical and physical assessments were performed in the study clinic by trained 
geriatricians and therapists, respectively.  
The InCHIANTI study protocol was approved by the Italian National Institute 
of Research on Aging ethical committee. All subjects received an extensive 
description of the study procedures and all gave written informed consent.  
 
Assessment of Dietary Intake 
Data on dietary intake were collected using the food-frequency questionnaire 
developed for the European Prospective Investigation into Cancer and nutrition 
(EPIC) study (Pisani P 1997, Palli D 2000). Although the EPIC questionnaire was 
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originally developed for and validated in middle-aged persons, our previous study 
suggested that this tool provides valid estimates of dietary intake when administered to 
older persons (Bartali B 2004). Specific software created for EPIC was used to 
transform data on food consumption into daily intake of energy, macro- and micro-
nutrients. A detailed description of this food-frequency questionnaire has been 
published elsewhere (Bartali B 2004). 
 
Assessment of Muscle Strength 
Knee extension was assessed using a hand-held dynamometer (Nicholas Manual 
Muscle Tester, BK-5474, Fred Sammons Inc, Burr Ridge, IL); this served in the 
current study as indicator of muscle strength. Participants, lying in lateral decubitus 
(opposite to the examined limb) with the hip and knee in 45° and 60° flexed positions, 
respectively, were asked to perform the task twice. The average of the results was used 
for the present analyses.  
 
Measure of Markers of Inflammation 
Blood samples were obtained from participants after a 12-hour fast and 15-minute rest. 
Aliquots of serum were stored at -80°C and not thawed until analyzed. We used ultra 
sensitive C-reactive protein (CRP) as indicator of inflammation. CRP was measured 
by ELISA using purified protein and polyclonal anti-CRP antibodies (Calbiochem, 
San Diego, CA) with standardization according to the WHO 1st International 
Reference Standard. Interleukin 6 (IL-6) and Tumor Necrosis Factor-a (TNF-α) were 
assessed by enzyme linked immunosorbent assay (ELISA) using ultrasensitive 
commercial kits (Human Ultrasensitive, BIOSOURCE International Inc., Camarillo 
California USA). The detectable limits were: 0.10 pg/ml for IL-6 and 0.09 pg/ml for 
TNF-α. The inter-assay coefficient of variation was 7% for both IL-6 and TNF-α. 
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Other Variables 
Presence of major chronic conditions was ascertained by trained geriatricians 
according to standard algorithms based on information on medical history, drug 
treatments, signs and symptoms, medical documents, and hospital discharge records 
(Guralnik JM 1995). Diagnostic algorithms were modified versions of those created 
for the Women’s Health and Aging Study (Guralnik JM 1995). Chronic conditions 
considered for the present analysis were: hypertension, diabetes, peripheral artery 
disease (PAD), stroke, angina pectoris, congestive heart failure (CHF), myocardial 
infarction, chronic obstructive pulmonary disease (COPD), Parkinson, cancer, and 
arthritis. The number of chronic conditions was used in the present analyses as 
continuous variable.  
Weight and height were measured in standardized positions and body mass 
index (BMI) was calculated as kg/m2. Smoking habits were classified as never 
smoked, former smoker, and current smoker.  Physical activity was defined as a) 
sedentary: completely inactive or light physical activity (i.e. walking) for less than 1 
hour/week; b) light: light physical activity for 2-4 hours/week; c) moderate: light 
physical activity for more than 4 hours/ week or moderate physical activity (i.e., 
gymnastics, swimming etc.) 1-2 hours/week; d) Intense: moderate physical activity for 
3 or more hours/week or walk 5 or more km/day.  
 
Statistical Analysis 
 General linear models were used to evaluate the effect of protein intake at baseline on 
change in muscle strength over three years of follow-up. We used muscle strength at 
follow-up as dependent variable, and protein intake at baseline as main independent 
variable. Muscle strength at baseline was entered in the model as independent variable 
to allow prediction of the effect of protein intake at baseline on subsequent change in 
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muscle strength (Frongillo and Rowe). The model was adjusted for age, sex, BMI, 
physical activity, energy intake and presence of chronic conditions. Since protein 
intake provides about 15% of the total energy intake, the energy provided by protein 
was excluded from the total energy intake to create a variable for non-protein energy 
intake that was used for the adjustment.  
Adjusted general linear models were used to examine the interaction between 
protein intake and CRP, IL-6 and TNF-α at baseline on muscle strength at follow-up. 
During the exploratory analyses, we used a 3-way interaction in the general linear 
model to exclude the possibility that the effect of the interaction between protein 
intake and inflammatory markers on change in muscle strength depended on the initial 
muscle strength. Furthermore, a 3-way interaction (protein intake*markers of 
inflammation*sex) was examined to verify whether the analyses had to be stratified by 
sex. In addition, we verified whether the effect of the interaction between protein 
intake and markers of inflammation on muscle strength at follow-up depended on the 
presence of diseases (protein intake*markers of inflammation*chronic conditions) 
(Table 2). To graphically show the interaction between protein intake and markers of 
inflammation on muscle strength and facilitate the interpretation of the results, we 
estimated muscle strength at follow-up according to specific values of protein intake 
and CRP at baseline (Figure). Additionally, the interaction between protein intake and 
markers of inflammation was examined selectively in persons without diseases.   
Although protein intake was entered in the model as g/day, the graph was 
constructed to show both the values of protein intake as entered in the model (g/day) 
and the corresponding amount of protein intake expressed in g/kg/day to facilitate the 
comparison with the RDA. According to the criteria used by the Institute of Medicine 
to extrapolate recommendations for protein intake, the calculation of protein intake 
expressed in g/kg/day was based on the average weight of the study population (70 
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kg). Since concentrations of CRP, IL-6 and TNF-α were not normally distributed, we 
log-transformed these variables to perform the analyses but showed the corresponding 
natural values of CRP in the graph. All analyses were performed using the SAS 





The comparison of characteristics between participants included and not included in 
the study is reported in Table 1. Participants excluded from the study were older, 
mostly female, with lower economical status, more sedentary, with more chronic 
conditions, higher levels of CRP and TNF-α and with lower energy and vegetable 
protein intake. The mean age of participants included in the study was 73 years and 
53% were women.  Descriptive information about the key variables is presented in the 
Appendix table. After adjustment for age, sex, BMI, physical activity, energy intake, 
chronic conditions, and muscle strength at baseline (Table 2), protein intake was not 
associated overall with change in muscle strength over three years of follow-up 
(p<0.686;). We found, however, a significant interaction between protein intake and 
CRP, IL-6 and TNF-α on change in muscle strength (Beta coefficient=0.020, p=0.003; 
Beta coefficient=0.016, p=0.058; and Beta coefficient=0.016, p=0.019; respectively). 
For example, increasing the log of CRP of 1 unit, the slope for the effect of protein 
intake on muscle strength increases of 0.02. Thus, in persons with high levels of 
inflammatory markers, lower protein intake was associated with a greater decline in 
muscle strength (Figure 2). In total, 8.1% of the population had levels of CRP > 10, of 
whom 1.5% had an intake of protein < 56 g/day and 1.5% had an intake of protein > 
91 g/day (Figure 2). These results were not attributable to the presence of chronic 
  25
conditions (Table 2). We also repeated the analyses selectively in participants without 
diseases, and the result on the interaction between protein intake and CRP on muscle 
strength did not substantially change (n=188; Beta =0.024; p=0.028).  
The 3-way interaction term with sex (protein intake*markers of inflammation*sex) 


















* Adjusted for age, sex, BMI, energy intake, chronic conditions, physical activity, and muscle strength 
at baseline 
^ The dashed line represents the mean muscle strength, adjusted for age and sex 




Figure 2.  Predicted muscle strength* at 3-year follow-up, according to protein intake 





















































Table 1. Main characteristics of the study participants 
 Included in  
the Study 
(n=598) 





General Characteristics Mean ± SD (or 
%) 
 Mean ± SD (or 
%) 
 p* 
Age (years; range: 65.1-92.8) 72.9 ± 5.6  79.3 ± 8.2  <.0001 
Gender (Female, %) 52.8  60.9  0.0060 
Education (years) 5.7± 3.3  5.3 ± 3.3  0.5424 
Living Alone (%) 16.9  20.7  0.1018 
Economical Status (sufficient, %) 68  49  <.0001 
Smoking (pack-year) 12.4 ±  20.3  12.4 ±  22.5  0.1192 
Physical Activity (sedentary, %) 10.25  40.9  <.0001 
Body Mass Index (kg/m2) 27.5 + 3.8   27.4 ± 8.2  0.1753 
Number of Chronic Conditions  1.2 + 1.1  4.6 ± 6.2  <.0001 
      
CRP (mg/L) 3.98 + 5.06  7.4 ± 13.2    <.0001 
IL-6 ultra-sensitive (pg/ml) 1.86 + 3.6  2.9 ± 5.07  0.1715 
TNF-α (pg/ml) 3.38 +  4.82  4.47 + 6.43    0.0076 
      
Energy Intake (kcal/day) 1999 ± 568  1776 ± 533  0.0026 
Total Protein Intake (g/day) 77 ± 20  70.5 ± 20.5  0.0242 
Vegetable Protein (g/day) 29.0 ± 9.5  25.5 ± 9.6  0.0062 
Animal Protein (g/day) 48.5 ± 15.0  45.0 ± 14.7  0.1822 
      
Muscle Strength at Baseline (kg) 15.9 ± 5.6     
Decline in Muscle Strength , % 43     
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Table 2. Effect of protein intake on subsequent change in muscle strength 





This study examined whether protein intake affects subsequent decline of muscle 
strength in older persons living in the community, and whether this effect was 
dependent on inflammation. The overall effect of protein on subsequent decline in 
muscle strength was not significant. We found, however, a significant interaction 
between protein intake and markers of inflammation on muscle strength. In persons 
  Beta (SE) p# 
   
Protein Intake -0.005 (0.012) 0.686 
    
Protein*Log(CRP)  0.020 (0.007) 0.003 
Protein*Log(IL-6)      0.016 (0.008) 0.058 
Protein*Log(TNF-α)  0.016 (0.006) 0.019 
   
Protein*Log(CRP)*sex 0.007 (0.014) 0.637 
Protein*Log(IL-6)*sex    -0.000 (0.018) 0.986 
Protein *Log(TNF-α)*sex   -0.021 (0.014) 0.145 
   
Protein*Log(CRP)*chronic c. -0.002 (0.006) 0.803 
Protein*Log(IL-6)*chronic c.    0.003 (0.008) 0.691 
Protein* Log(TNF-α)*chronic c.   -0.008 (0.006) 0.198 
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with high levels of inflammatory markers, lower protein intake was associated with a 
greater decline in muscle strength.  
Previous studies found a significant association between oral aminoacids 
supplementation and muscle strength in older persons with low physical activity and 
in geriatric patients (Scordamiglio R 2005, Dehail P 2005). This is the first 
longitudinal study, however, on the relationship between protein intake and muscle 
strength.   
The result on the interaction between protein intake and inflammatory markers 
on muscle strength could be attributable, at least in part, to the complexity of cellular 
and metabolic activities involved in the pro-inflammatory state that may alter the 
pattern of regulation of protein metabolism and may impose priorities. In fact, the 
systemic inflammatory response is associated with oxidative stress (Volpi E 2003) and 
stimulates muscle protein turnover to allow for the adaptation to this stressful 
condition and depresses rates of protein synthesis (Smith KL 1993). Although this 
process is a protein- and energy-demanding response, the amino acids released by 
tissue protein breakdown represent a substrate for the synthesis of numerous proteins 
and peptides involved in the immune system, with consequent reduction in plasma 
amino acid concentration (Suliman ME 2005). Previous studies have shown that 
amino acid availability is critical in the regulation of muscle protein metabolism 
(Biolo G 1997; Rennie MJ 1983). Thus, high levels of inflammatory markers in older 
persons may result in an increased requirement for dietary intake of proteins to create 
a more anabolic environment, and reduce the reliance of amino acids from muscle 
protein breakdown. In line with our findings, previous studies (Campbell WW 1994, 
Campbell WW 2001) suggested that older persons may require a higher protein intake 
(1.0 g/kg/day) than the current Dietary Recommended Intake (0.8 g/kg/day) (Food and 
Nutrition Board 2001).    
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The main limitation of this study is that protein intake was assessed using a 
food frequency questionnaire. Thus, the accuracy of the observed associations might 
be affected by information bias. The distribution of errors, however, is unlikely related 
to the outcome. Consequently, the observed results are likely to be underestimated.  
An important strength of this study is that we used an objective measure of muscle 
strength that is highly reliable (Cesari M 2004). Furthermore, these results are adjusted 
for non-protein energy intake and, consequently, show the “pure” effect of protein 
intake on muscle strength, independent of the intake of energy from other sources. We 
repeated, however, all the analyses adjusting for total energy intake instead of non-
protein intake and the results did not substantially change.   
In conclusion, we found that the overall effect of protein intake on subsequent 
decline in muscle strength was not significant, but there was a significant interaction 
between protein intake and markers of inflammation on decline in muscle strength. In 
persons with high levels of inflammatory markers, lower protein intake was associated 
with a greater decline in muscle strength, independent of the presence of diseases. 
These findings suggest that high levels of markers of inflammation may alter protein 
metabolism and the efficiency of protein utilization. Furthermore, the current 
recommended dietary intake of protein (0.8 g/kg/day) extrapolated from the middle-
aged population may not be appropriate for the maintenance of physical function in 
older persons.  
To our knowledge, this is the first longitudinal study on the effect of protein 
intake and inflammatory markers on muscle strength in older persons. Further studies 
are needed to confirm these results, and caution should be used in recommending 
higher protein intake to older persons with specific chronic diseases (e.g., kidney 
diseases). These results may help to understand the etiology of sarcopenia and to 
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Low Vitamin E Concentration is a Determinant of Decline in Physical Function 
among Older Persons Living in the Community 
 
The decline in physical function that occurs with aging often represents the early stage 
of a continuum leading to disability and other important adverse outcomes such as 
institutionalization. Although the prevalence of disability declined from 1982 to 2004 
(Manton KG 2006), the absolute number of disabled older persons is projected to 
increase as the population ages over the next two decades (Census Bureau 2000), with 
a detrimental effect on the health-related costs and long-term care (Guralnik JM 2002). 
Thus, disentangling the mechanisms underlying the disablement process has been 
identified as a high research priority (Landefeld CS 1998; Ebrahim S 1999; Jette AM 
1999) and the assessment of physical function has become an essential feature of the 
comprehensive clinical evaluation of older persons (Applegate WB 1990). 
Standardized measures such as the Short Physical Performance Battery (SPPB) 
(Guralnik JM 1994; Guralnik JM 1995) have been developed to study the etiology and 
progression of functional decline and disability.  
Poor nutrition may play a role in the disabling process through different 
mechanisms (Bartali 2007), for example by increasing the levels of markers of 
inflammation and oxidative stress (Esposito K 2004, Lopez-Garcia E 2004, Lopes HF 
2003, Di Mascio P 1991) with subsequent muscle or neuronal cell damage (Mecocci P 
1999, Coyle JT 1993) and decline in physical and cognitive function (Cesari 2005, Lu 
T 2004). Despite this strong theoretical basis, there is relatively little empirical 
evidence linking poor nutrition to decline in physical function. Previous studies 
(Snodow DA 1996) and our recent findings (Cesari 2004, Bartali 2006, Semba 2006, 
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Bartali 2006) have shown that poor nutrition is associated with reduced physical 
function, frailty and disability in older persons. These studies, however, have been 
limited by their cross-sectional design (Snodow DA 1996, Cesari 2004, Bartali 2006) 
or non-representative samples, including for example only older women with some 
level of difficulty in physical function (Bartali 2006, Semba 2006).   
The purpose of this study was to determine whether a low concentration of 
nutrients is associated with subsequent decline in physical function. We used data 
from a population-based, longitudinal study of community-living older men and 






InCHIANTI is a population-based study of risk factors contributing to decline in 
physical function in older persons living in two municipalities located in Tuscany, 
adjacent to the city of Florence. The design and methods on data collection for 
InCHIANTI have been described in detail elsewhere (Ferrucci 2000).  In brief, 
persons were randomly selected from the population registry, and 1155 persons aged 
65 years or older participated in the study. The response rate was 91.6%.  
Data collected at baseline and during a 3-year follow-up assessment were used for the 
current study. As shown in Figure 3, the exclusion criteria were missing information 
on the Short Physical Performance Battery (SPPB) at either baseline or follow-up, and 
SPPB <3 at baseline (to exclude participants with very poor functional status). 

















Trained interviewers administered a structured assessment at the participant’s home, 
including questions on education, socio-economical status, household composition, 
health and functional status. Cognitive status was assessed by the Mini-Mental State 
Examination (MMSE) (Folstein MF 1975) and depressive symptoms were assessed 
using the Center for Epidemiological Studies-Depression scale (CESD) (Irwin M 
1999). Participants were asked to specify their level of physical activity, which was 
subsequently classified as “light" if they reported walking outside their home for less 
than 4 hours/week (Elosua R 2005). A validated food frequency questionnaire was 
administered to estimate energy intake (Pisani P 1997, Bartali B 2004). 
A medical history and physical assessment were performed in the study clinic 
by physicians and therapists, respectively. Weight and height were measured 




















w/o SPPB at F 
Figure 3. Profile of the Study 
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calculated as kg/m2. The presence of major chronic conditions was established by 
trained geriatricians according to algorithms based on information from the medical 
history, drug treatments, signs and symptoms, and hospital discharge records 
(Guralnik, Fried 1995). The number of chronic conditions served as the indicator of 
comorbidity. 
 
Assessment of Serum Nutrients  
Fasting blood samples were obtained by venipuncture between 7.00 am and 10.30 am.  
Folate, vitamins B-6, and B-12 were obtained by centrifuging blood collected in 
evacuated tubes without anticoagulant and were stored at -80 °C. Vitamin B-6 was 
measured by HPLC (Immundiagnostik, Bensheim, Germany) and vitamin B-12 and 
folate by radioimmunoassay (ICN Pharmaceuticals, New York, NY). The minimum 
detectable concentrations were 0.6 ng/mL for folate, 0.2 ng/mL for vitamin B-6, and 
75 pg/mL for vitamin B-12; the intraassay CVs were 4.1% for folate, 2.8% for vitamin 
B-6, and 11.2% for vitamin B-12; and the interassay CVs were 7.1% for folate, 4.1%  
for vitamin B-6, and 12.3% for vitamin B-12. Plasma vitamin E (α-tocopherol) 
concentrations were measured by reversed-phase HPLC as previously described 
(Martin A 1995). Triplicate analysis of the reference samples provided by the 
American Association for Laboratory Accreditation (Washington, DC) showed an 
intrabatch CV of 3% and an interbatch CV of 4.2%. 25(OH)-vitamin D was measured 
by RIA (DiaSorin Inc., Stillwater, MN, USA), after extraction of samples with 
acetonitrile. Intra- and inter-assay CVs were 8.1. Intra- and interassay CVs were <3.0 
and 5.5 %, respectively.  Iron was assessed using a colorimetric assay (Roche 
Diagnostics, Mannheim, Germany). The analytical sensitivity was 5 mg/dL, and the 
measuring range was 5 to 1000 mg/dL. 
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Assessment of Physical Function  
The score on the SPPB was derived from performance on three objective tests of 
physical function: four-meter walking speed, repeated chair rises, and standing 
balance in progressively more challenging positions (Guralnik 1994).  Walking speed 
was defined as the best performance (time) of two walks at usual pace over a four-
meter course. For the chair-stand test, participants were asked to rise and sit down five 
times as quickly as possible with their hands folded across the chest; and performance 
was expressed as total time to complete the test. For the standing-balance test, 
participants were asked to stand in three progressively more difficult positions for 10 
seconds each: side-by-side feet standing, semi-tandem, and full-tandem position.  
For each of these three performance tests, participants received a score from 0 
to 4, with a score of 0 indicating the inability to complete the test and 4 the highest 
level of performance. The scores were summed to create a total score ranging from 0 
to 12 with higher scores representing better performance. Previous studies have 
demonstrated that older, non-disabled persons with low SPPB score are at high risk of 
developing disability (Guralnik 1995), and reported a test-retest correlation of 0.89 for 
walking speed (Nevitt MC 1989), of 0.73 for repeated chair rises (Seeman TE 1994), 
and of 0.97 for standing balance (Winograd CH 1994). 
 
Statistical Analysis 
Descriptive analyses were performed to provide information on general characteristics 
of the study population. The SPPB score at baseline was subtracted from the score at 
the 3-year follow-up to identify participants who declined in physical function. 
Because the loss of 1 point in the SPPB score is considered a clinically meaningful 
(Perera S 2006) and potentially modifiable change (Pahor 2006), a dichotomised 
variable (1=loss of at least 1 point; 0=no loss) was created and used as the primary 
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outcome in the current study. Exploratory analyses examined the interaction between 
the concentration of nutrients and SPPB score at baseline on SPPB score at follow-up 
to evaluate whether the effect of concentration of nutrients on change in SPPB score at 
follow-up differed across the levels of SPPB at baseline and allow ranking in the same 
category participants who lost > 1 points.  
As in a previous study (Bartali 2006), low concentration for each nutrient was 
defined as the lowest quartile of the baseline distribution. The cut-off thresholds were 
24.9 µmol/L for α-tocopherol, 275 pg/mL for vitamin B12, 4.35 ng/mL for vitamin 
B6, 1.9 ng/ml for folate, 30.5 µg/dL for 25(OH)-vitamin D, and 55 µg/dL for iron. 
This analytical approach was used because nutrient requirements for older persons are 
inadequately documented and cut-off for deficiencies extrapolated from the older 
population have not been defined (IOM 2006). 
Logistic regression models were used to evaluate the association between low 
concentration of the specific nutrients and subsequent decline in physical function. 
The odds ratios were calculated for the lowest quartile of each nutrient, using the other 
three quartiles combined as the reference group. Four separate logistic models were 
used for each nutrient: 1) unadjusted; and adjusted for 2) age; 3) age and sex; 4) age, 
sex, education, marital status, household composition, smoking, physical activity, 
number of diseases, BMI, CESD, and MMSE score. Finally, the full adjusted model 
was further adjusted for energy intake.  
Two additional and complementary analytical approaches (multiple general 
linear models and classification and regression trees (CART) analysis) were used to 
more completely evaluate the association between low concentration of nutrients and 
subsequent decline in physical function, and to confirm the validity of our primary 
results. Separate general linear models were used to examine whether serum levels of 
nutrients at baseline (continuous) were associated with the SPPB score at follow-up 
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(continuous), after adjustment for potential confounders as in the full adjusted model 
and the SPPB score at baseline (continuous). Finally, CART analysis was performed 
to identify a hierarchical order of and potentially complex interactions between the 
concentration of different nutrients (continuous) and the other variables included in the 
full logistic model (Model 4) with the outcome of decline in physical function 
(dichotomous). CART analysis uses recursive portioning to define the optimal cut-off 
point for continuous predictors and determines homogeneous groups having the 
largest difference in the outcome variable (minimum misclassification error rate) 
(Allore H 2005). Interactions between independent variables occur recursively instead 
of simultaneously as in linear regression. This results in a classification rule with the 
optima cut-point for continuous variables and is represented as a tree. Cross validation 
was applied and the tree with the smallest deviance (sum of squares for residuals) was 
considered with the optimal size (Allore H 2005). The CART analysis was performed 
using S-PLUS statistical software (S-PLUS 2000). All other analyses were performed 





The comparison of characteristics between participants included and excluded from 
the study is reported in Table 3. Participants excluded from the study were older, had 
lower level of physical activity, and lower cognitive and physical function. Among 
participants included in the study, the mean age was 73.7 years, 54% were women, 
and the mean decline in SPPB score was 1.1 points. During the 3-year follow-up, 
50.4% of the population declined of at least 1 point in SPPB score. Further descriptive 
information about the key variables is presented in the Appendix table. 
  41
In the unadjusted analyses (Table 4), low concentration of both vitamin E and 
vitamin D were significantly associated with subsequent decline in physical function, 
with odds ratios of 1.65 (CI=1.17-2.34, p=0.005) and 1.45 (CI=1.03-2.05, p=0.033), 
respectively. In the full adjusted model, the association between vitamin E and physical 
function remained statistically significant, with an odds ratio of 1.62 (CI=1.11-2.36; 
p=0.012). Thus, participants with low concentration of vitamin E were 1.62 times more 
likely to decline in SPPB score compared to the other group. Even after adjustment for 
energy intake the results did not change appreciably (OR=1.63; CI=1.12-2.38; p=0.011). 
As previously suggested (Traber MG 2000), we adjusted for total cholesterol the 
analyses on vitamin E. Since cholesterol-adjusted and cholesterol-unadjusted models 
yielded similar results, cholesterol-unadjusted models are presented.  
Since the effect of folic acid on decline in physical function was opposite than 
expected (OR=0.72) and marginally significant (p=0.095), we further investigated this 
result and hypothesized that participants with high levels of folic acids at baseline were 
those who received integration of folic acid because of the presence of health-related 
problems. Confirming this hypothesis, we found that selectively in participants with 
levels of folic acid higher than the mean (3.3 ng/mL), levels of folic acid were positively 
and significantly associated with higher number of chronic conditions (Beta=0.41; 
p=0.02, after adjustment for age).   
In the multivariate general linear regression analyses, only a lower 
concentration of vitamin E (continuous) was significantly associated with lower SPPB 
score at follow-up, after adjusting for potential confounders and the SPPB score at 
baseline (Beta=0.023; p=0.01). After further adjustment for total energy intake, the 
result did not substantially change (Beta=0.023; p=0.01). Finally, the effect of vitamin 
E on change in the SPPB score at follow-up did not depend on the initial SPPB score 
(interaction term: Beta =-0.005; p=0.328). 
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Table 3. Main characteristics of the study participants aged 65 years or older 
 Included in  
the Study (n=698) 
 Excluded from 
the Study (n=457) 
  
 
 Mean ± SD (or %)  Mean ± SD (or %)  p* 
Age (years) 73.7 + 6.2  79.4 + 8.3  <.0001 
Gender (Female, %) 54.4  60.3  0.051 
Living Alone (%) 18.3  19.21  0.7087 
Body Mass Index (kg/m2) 27.5 + 3.9  27.4 + 3.4  0.242 
Physical Activity      <0.0001 
         Sedentary 13.3  40.8   
         Light 46.3  36.0              
         Moderate/Intense  40.4  23.2   
Smoking (pack-year)  11.9 + 19.6  13.1 + 23.8  0.0196 
Mini Mental State 
Examination  
25.6+3.1  21.8+3.4  <.0001 
Depression (CESD scale) 11.1+3.8  11.7+ 3.4  0.5660 
Number of Diseases 0.4+ 0.7  0.6+ 0.8  0.0691 
Levels of Nutrients      
Vitamin E (ng/ml) 30.6+8.3  29.2+ 7.3  0.1492 
Vitamin B12 (pg/ml) 450.0+333.2  469.5+304.4  0.1631 
Vitamin B6 (ng/ml) 7.2+6.2  6.2+ 9.1  0.4295 
Folic Acid (ng/ml) 3.4+2.1  3.2+ 1.7  0.4634 
Vitamin D (ng/ml) 53.9+37.3  43.5+ 24.7  0.0101 
Iron (ng/ml) 84.8+25.2  80.0+ 23.4  0.1604 
Physical Function      
SPPB at baseline 10.7+ 1.9  7.5+ 4.5  <.0001 
43 
             Table 4. Logistic regression models^ examining the effect of low levels of nutrients (1st Quartile vs. upper three quartiles)    

















    ^ Nutrients were entered in separate models;  
    *Outcome=dichotomized variable (1=loss of at least 1 point in SPPB score; 0=no loss)  
      Model 1: not adjusted; Model 2: adjusted for age; Model 3: adjusted for age and sex; Model 4: age, sex, education, marital status, household    
      composition, smoking (pack-year), physical activity, number of diseases, BMI, CESD, MMSE. 
  Model 1  Model 2  Model 3  Model 4 
  OR (95%CI) p  OR (95%CI) p  OR (95%CI) p  OR (95%CI) p 
Vit. E   1.65 (1.2-2.3) 0.005  1.54 (1.1-2.2) 0.021  1.62 (1.1-2.4) 0.010  1.62 (1.1-2.4) 0.013 
Vit. B12   1.17 (0.8-1.6) 0.362  0.99 (0.7-1.4) 0.979  1.03 (0.7-1.5) 0.868  1.07 (0.7-1.5) 0.735 
Vit. B6   1.33 (0.9-1.9) 0.106  1.02 (0.7-1.5) 0.905  1.06 (0.7-1.5) 0.763  1.04 (0.7-1.5) 0.824 
Folic Ac.   0.81 (0.6-1.1) 0.210  0.69 (0.5-1.0) 0.045  0.71 (0.5-1.0) 0.063  0.73 (0.5-1.1) 0.095 
Vit. D   1.45 (1.0-2.1) 0.033  1.08 (0.7-1.6) 0.691  0.98 (0.7-1.4) 0.908  0.93 (0.6-1.4) 0.700 
Iron  1.15 (0.8-1.6)    0.418  1.11 (0.8-1.6) 0.574  1.11 (0.8-1.6) 0.584  1.12 (0.8-1.6) 0.556 
43 
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As shown in Figure 4, among the 17 factors initially selected for the CART analysis 
(the 6 nutrients and the 11 covariates used in the fully adjusted models), age and 
vitamin E were identified as the strongest determinants of decline in physical function. 
Persons aged > 80 years had the highest risk of declining in physical function 
(p=84%), while those aged < 70 years had the lowest risk. Among persons aged 70 to 
80 years, the strongest predictor of decline in physical function was a concentration of 
vitamin E < 32 umol/L (p=60%). The misclassification error rate for the CART 

























Vit . E < 32mcg/ml
n=244 
p=60% 
Vit. E > 32mc
n=153
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n=92 
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*Decline of at least 1 point;  
Independent variables= age, sex, education, marital status, household composition, smoking  
Figure 4. Classification Tree for Decline in SPPB 
physical activity, number of diseases, BMI, CESD, and MMSE  




The purpose of this study was to determine whether a low concentration of nutrients 
was associated with subsequent decline in physical function among older men and 
women living in the community. Using three different analytical approaches, we 
consistently found that a low concentration of vitamin E was associated with 
subsequent decline in physical function.  
Vitamin E is the major lipid-soluble antioxidant and plays a critical role in the 
defence from oxidative stress by donating electrons and neutralizing free radicals. 
Low levels of vitamin E may affect this neutralization by creating an imbalance and, 
consequently, a highly reactive milieu. Since molecular oxygen promptly accepts 
unpaired electrons to form reactive oxygen species (ROS) (Cadenas E 2000), this 
imbalance may lead to excessive formation of ROS and, consequently, to oxidative 
stress that may cause DNA (Marnett LJ 2000), muscle (Moylan JS 2007) and neuronal 
(Hensley K 2006) damage, and lipid peroxidation (Voss P 2006).  This chain of events 
may explain, at least in part, our findings on the association between low 
concentrations of vitamin E and subsequent decline in physical function. The 
hypothesis that antioxidants play a role in the etiology of decline in physical function 
and disability is supported by our previous findings (Bartali 2006, Semba 2006, 
Bartali 2006, Cesari 2004) and other studies suggesting that oxidative stress is 
involved in muscular fatigue (Finaud J 2006) and that antioxidants play a preventive 
role in muscle damage by reducing oxidative injury (Clarkson 2000, Fano 2001). 
Interesting, vitamin E plays a differential role in oxidative metabolism of different 
muscle fibers (Type I and type II). Type I fibers are plentiful in myoglobin and 
mitochondrial enzymes and replenish phosphocreatine more efficiently via oxidative 
phosphorylation than do type II fibers (Pette 1986) which theoretically lead to higher 
  46
production of free radicals. Thus, it has been suggested that type I (slow) fibers require 
more vitamin E than type II (fast) (Pette 1986). Furthermore, high concentration of 
vitamin E has been associated with increased levels of creatine kinase activity that 
may indicate increased skeletal muscle repair (Evans WJ 2000). In addition, vitamin E 
deficiency has been associated with increased lipid peroxidation (Buettner GR 1993) 
and risk of cardiovascular diseases (Diaz MN 1997), as well as with peripheral 
neuropathy and neurological deficit (Traber MG 1987; Argyriou AA 2005; Puri V 
2005; Howard L 1982).  
Thus, at least three different mechanisms may explain the effect of low 
concentration of vitamin E on subsequent decline in physical function: 1) increased 
oxidative stress leading to muscle, neuronal or DNA damage (Burton GW 1982), and 
to the exacerbation of atherosclerosis (Ryszawa N 2006) or other pathologic 
conditions (Diaz MN 1997, Maier CM 2002; Esposito K 2006); 2) alteration of muscle 
fiber types (Pette 1996; Neville 1983); and 3) peripheral neuropathy and neurological 
deficit (Traber MG 1987; Howard 1982). Although a low concentration of the other 
nutrients considered in this study could potentially play a role on the decline in 
physical function through different mechanisms, they were not statistically significant 
and this result needs to be further investigated. 
To our knowledge, this is the first longitudinal study to have examined the 
effect of low concentrations of different nutrients on subsequent decline in physical 
function using a population-based sample of older men and women living in the 
community. We used objective measures for the evaluation of both the exposure 
(concentration of nutrients) and the outcome (decline in physical function). Hence, our 
results are not biased by self-report. Furthermore, we used an indicator of physical 
function derived from the assessment of three different performance tests, which 
increases its reliability and accuracy (Stewart 1988; Guralnik 2000). Finally, the 
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validity of our findings is strengthened by the use of three different analytical 
approaches, each of which demonstrated the same result: low vitamin E concentration 
was associated with subsequent decline in physical function. Of note, the cut-off of 
vitamin E selected by the CART analysis was 32 mcg/ml, and > 30 mcg/ml is the cut-
off used to define optimal status of vitamin E (Traber MG 1996). Hence, our results 
have face validity.  The third quartile for vitamin E in the sample was 34.90 (see 
Appendix table), which is close to the cut-off selected by CART.  This suggests that, if 
there is a non-linear relationship between vitamin E and decline in physical function 
(e.g., a threshold), it cannot be identified within the range of the sample.  This was 
confirmed by adding a quadratic term to the continuous analysis and finding that it 
was not significant. 
Our findings, however, should be interpreted in light of several limitations. 
The loss to follow-up of respondents may have biased the results. Non participants to 
follow-up were older, more sedentary, had lower cognitive function and SPPB score 
compared to participants to follow-up. In longitudinal studies of older persons, age-
related problems such as the reduction of cognitive function, morbidity and mortality 
are inevitable causes of attrition (Lui 1989, Deeg DJH 2002), leading to loss of power 
and underestimation of changes over time (Deeg DJH 2002). Thus, our results are 
likely to be underestimated. Furthermore, InCHIANTI is an Italian population-based 
sample, raising potential concerns about the generalizability of the findings. It is 
unlikely, however, that the basic biological mechanisms underlying decline in physical 
function with age differ substantially from one country to another. Because the 
percentage of participants in this study who used nutritional supplements was very low 
(4%), in contrast to the United States (Murphy SP 2007), we had a unique opportunity 
to evaluate the “pure effect” of poor nutrition on the decline in physical function.  
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In conclusion, the current study provides empirical evidence that low 
concentration of vitamin E is associated with subsequent decline in physical function 
in a population based sample of older persons living in the community. These 
findings, however, do not suggest that vitamin E supplementation would prevent 
physical function decline, but rather provide solid base that poor nutrition contributes 
to the decline in physical function in older persons. This study has important 
implications for clinical trials or interventions to reduce functional decline and, 
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Effect of Leptin, Ghrelin and Inflammatory Markers on Energy Intake in 
Older Persons: a Longitudinal Prospective 
 
Undernutrition is highly prevalent in older persons (Pirlich M 2001) and is associated 
with reduced adaptive response to physiologic and pathologic conditions (Mowé 
1994), and with increased vulnerability to adverse outcomes such as morbidity (Mowé 
1994), frailty (Bartali 2006) and disability (Bartali 2006). Undernutrition has been 
identified as one of the “10 hot topics” in aging research (Morley 2004) and the term 
“anorexia of aging” has been coined to describe the physiologic decline in food intake 
that occurs with aging (Morley 2001, Morley 1997), predisposing to the development 
of undernutrition (Morley 1997). 
Food intake is regulated by a complex system of neural and chemical signals 
that modulate short and long-term feeding behaviors (Horwitz BA). Specific hormones 
and inflammatory markers may play a central role in orchestrating the “feeding 
network”. In particular, ghrelin has been recently identified as a gastric peptide 
hormone that stimulates food intake (Kojima M 1999). Leptin is a hormone secreted 
by adipocytes that induces satiety, and leptin receptors are expressed by brain neurons 
involved in regulating energy intake (Schwartz MW). In addition, increased levels of 
inflammatory markers are considered important factors contributing to anorexia of 
aging (Morley 1997, Langhans W 1999).  
Most of the studies on the effect of these hormones and inflammatory markers 
on energy intake, however, have been preclinical (Mattison JA 2005; Iossa S 1999; 
Horwitz BA 2002), have evaluated postprandial responses (Di Francesco 2006; Sturm 
K 2003; ), and have been limited to participants with specific pathologic conditions 
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(Bossola M 2005; Schwenk A 2003). The long-term effect of these hormones and 
inflammatory markers on energy intake in the general older population is unknown. 
The aim of this study was to determine whether the concentration of ghrelin, leptin or 
inflammatory markers is associated with accelerated decline in energy intake in older 





InCHIANTI (Invecchiare in Chianti, aging in the Chianti area) is a study of risk 
factors contributing to the decline of mobility in late life, conducted in two 
municipalities adjacent to the city of Florence (Italy). Details of the study have been 
described elsewhere (Ferrucci L 2000). In brief, 1299 participants aged 65 years or 
more were randomly selected from the population registry. Of the 1260 participants 
who were eligible (39 had died or moved away from the area), 1155 (91.6%) 
participated in the study. After excluding those who had cancer at baseline (n=67) and 
those who refused (n=101), emigrated (n=16) or died (n=127) during the three-year 
follow-up, the final analytical sample included 844 participants.  
Trained interviewers administered two structured questionnaires at the 
participant’s home: 1) a general questionnaire to collect information on socio-
demographic characteristics, economical status, household composition, physical 
activity, functional and health status; and 2) a detailed food frequency questionnaire to 
estimate dietary intake. The InCHIANTI study protocol was approved by the ethical 
committee of the Italian National Institute of Research on Aging. All subjects received 
an extensive description of the study procedures and signed the informed consent.  
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Assessment of Dietary Intake  
Data on dietary intake were collected using the food-frequency questionnaire 
developed for the European Prospective Investigation into Cancer and nutrition 
(EPIC) study (Pisani P 1997). Although the EPIC questionnaire was originally 
developed for and validated in middle-aged persons, our previous study suggested that 
this tool provides valid estimates of dietary intake when administered to older persons 
(Bartali 2004). Specific software created for EPIC was used to transform data on food 
consumption into daily intake of energy, macro- and micro-nutrients. A detailed 
description of this food-frequency questionnaire has been published elsewhere (Bartali 
2004). 
 
Assessment of Hormones and Inflammatory Markers 
Blood samples were obtained from participants after a 12-hour fast and 15-minute rest. 
Aliquots of serum were stored at -80°C and not thawed until analyzed. Serum leptin 
was determined in duplicate using a commercially available enzyme linked 
immunosorbent assay kit (Human Endocrine LINCOplex Kit, LINCO Research, Inc., 
St. Charles, Missouri). The intra- and interassay coefficients of variation (CV) ranged 
from 2.6% to 6.2%. Ghrelin concentration was measured using ELISA assay (Human 
Ghrelin ELISA kit, Phoenix Pharmaceuticals, Inc., Belmont, CA, USA). The 
minimum detectable concentration was 0.1 ng/mL. The intra-assay CV was less then 
5% and inter-assay CV was less then 14%. C-reactive protein (CRP), tumour necrosis 
factor (TNF)-α and interleukin-6 were used as inflammatory markers. High-sensitivity 
CRP was measured in duplicate by enzyme-linked immunosorbent assay using 
purified protein and polyclonal CRP antibodies (Calbiochem, San Diego, California) 
with standardization according to the World Health Organization’s reference standard. 
The minimum detectable concentration was 0.03 mg/L, and the interassay coefficient 
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of variation was 5%. TNF-α and IL-6 and were assessed by enzyme linked 
immunosorbent assay (ELISA) using ultrasensitive commercial kits (Human 
Ultrasensitive, BIOSOURCE International Inc., Camarillo California USA). The 
detectable limits were: 0.09 pg/ml for TNF-α, and 0.10 pg/ml for IL-6. The inter-assay 
coefficient of variation was 7% for both TNF-α and IL-6. 
 
Other Variables 
Presence of major chronic conditions was ascertained by trained geriatricians 
according to standard algorithms based on information on medical history, drug 
treatments, signs and symptoms, medical documents, and hospital discharge records 
(Guralnik JM 1995). Diagnostic algorithms were modified versions of those created 
for the Women’s Health and Aging Study (Guralnik JM 1995). Chronic conditions 
considered for the present analysis were: hypertension, diabetes, peripheral artery 
disease (PAD), stroke, angina pectoris, congestive heart failure (CHF), myocardial 
infarction, chronic obstructive pulmonary disease (COPD), Parkinson, cancer, and 
arthritis. The number of chronic conditions was used in the present analyses as 
continuous variable.  
 
Statistical Analysis 
  General linear models were used to evaluate the effect of leptin, ghrelin and 
inflammatory markers on accelerated decline in energy intake during three years of 
follow-up. Energy intake at follow-up was used as dependent variable, and leptin, 
ghrelin and inflammatory markers were included in separate models as main 
independent variables. The analyses were adjusted for age, sex, presence of chronic 
conditions, and for energy intake at baseline to allow prediction of the effect of leptin, 
ghrelin, and inflammatory markers at baseline on accelerated change in energy intake 
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during three years of follow-up (Frongillo and Rowe 1999). Furthermore, general 
linear models were used to examine the interaction between baseline concentration of 
leptin, ghrelin, CRP, TNF-α, IL-6 and: 1) age; 2) sex ; 3) sex and age on energy intake 
at follow-up. Since it has been suggested that there may be a bidirectional relationship 
between hormones and cytokines (Langhans W 1999), separate general linear models 
were used to mutually adjust the significant associations of hormones (leptin) and 
inflammatory markers (CRP and IL-6) at baseline with energy intake at follow-up, 
taking advantage of the chronological aspect of the longitudinal data. Since Leptin, 
CRP, TNF-α, and IL-6 were not normally distributed, we log-transformed these 






The difference in general characteristics between participants included and excluded 
from the study is reported in Table 5. In general, women who were excluded from the 
sample were older (p<0.0001) and with lower physical activity (p<0.0001), reduced 
cognitive function (p<0.0001) and higher concentrations of CRP (p=0.0048).  
Descriptive information about the key variables is presented in the Appendix table. 
The associations between ghrelin, leptin and inflammatory markers at baseline with 
energy intake at follow-up are shown in Table 6. High concentration of leptin was 
significantly associated with accelerated decline in energy intake. In particular, an 
increase in leptin of 2.7 ng/mL (corresponding to 1 natural logarithm of leptin) was 
associated with a decrease in energy intake of 38 Kcal. The main effect of ghrelin was 
not statistically significant but we found a marginally significant interaction between 
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ghrelin and age (Beta for ghrelin=5214; Beta for ghrelin*age=-74.0, p=0.07). 
Increasing age of 1 unit, the slope of ghrelin decreased of 74 kcal. Thus, the slope of 
ghrelin in persons aged, for example, 65 years was 404 kcal (5214 -(74*65)) per unit 
increase of ghrelin.  
Furthermore, the main effect of CRP and IL-6 on decline in energy intake was 
not significant, but there was a significant interaction between these inflammatory 
markers and sex (Beta for CRP(log)=-122; Beta for CRP(log)*sex=70.0, p=.020 Beta 
for IL-6(log)=-136; Beta for IL-6(log)*sex=85, p=.028). In men, high concentration of 
CRP and IL-6 was associated with greater decline in energy intake compared to 
women, after adjustment for potential confounders including chronic diseases. In 
particular, the sex difference was 70 kcal and 85 kcal per unit increase of log CRP and 
log IL-6, respectively.  
The effect of CRP(log) and IL-6 (log) on energy intake was negative in males 
(-52 kcal and -51 kcal per unit increase of CRP(log) and IL-6(log), respectively and 
positive in females (18 kcal and 34 kcal per unit increase of CRP(log) and IL-6(log), 
respectively). When the significant associations were mutually adjusted, the results on 
leptin as well as the interaction between CRP and IL-6 and sex did not substantially 
change (Table 7). Furthermore, the findings on significant interactions were further 








Table 5. Main characteristics of the study participants at baseline 
. 
 Included in  
the Study (n=844) 
 Excluded from 
the Study (n=311) 
  
 
 Mean ± SD (or %)  Mean ± SD (or %)  p* 
Age (years) 74.7+ 7.0  79.3 + 8.3  <.0001 
Gender (Female, %) 60.8  55.2  0.091 
Living Alone (%) 17.4  22.2  0.065 
BMI (kg/m2) 27.4 + 4.1  27.6+ 4.1  0.138 
Physical Activity24      <.0001 
         Sedentary 19.19  37.3   
         Light 44.08  36.33   
         
Moderate/Intense  
36.73  26.37   
Smoking (pack-year) 12.5 + 20.9  13.1 + 23.8  0.0836 
MMSE score25 25.0 + 4.0  21.6 + 7.2  <.0001 
CESD score26 11.3 + 3.8  11.7 + 3.8  0.568 
Number of Diseases 0.99 + 0.95  1.0 + 1.0  0.239 
Energy Intake (kcal) 1935 + 560  1774 + 555  0.056 
Leptin (ng/mL) 13.37+ 17.07  14.54+ 18.71  0.306 
Ghrelin (ng/mL) 0.28 + 0.05  0.28+ 0.06  0.968 
IL-6 (pg/mL) 2.11 + 3.53  2.94 + 6.17  0.213 
TNF-α (pg/mL) 3.75 + 5.61  4.15 + 5.50  0.534 
CRP (µg/mL) 4.82 + 7.73  7.48 + 13.8  0.005 
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Table 6. Effect of hormones and inflammatory markers on energy intake during 3-






















1 Results reported in each row were derived from separate models adjusted for age,  
sex (1=male; 2=female), energy intake at baseline and chronic conditions.  
2 Intercept (SE)= 1747 kcal (225);  
3 Intercept (SE)= 1735 kcal (219); Beta CRP (log)=-122; 
4 Intercept (SE)= 1701 kcal (220); Beta IL-6 (log)=-136;  
 
  Beta (SE)  p1 
Leptin (log) 2  - 38.0 (18.4)  0.039 
Leptin (log)*age  2.43 (2.34)  0.298 
Leptin (log)*sex  19.4 (37.2)  0.602 
     
Ghrelin (ng/mL)  -309.4 (301)  0.304 
Ghrelin (ng/mL)*age  -74.0 (41.2)  0.072 
Ghrelin (ng/mL)*sex  -973.1 (609)  0.106 
     
CRP (log)    -16.2 (15.5)  0.296 
CRP (log)*age  -0.17 (2.07)  0.934 
CRP (log)*sex3  70.0 (30.1)  0.020 
     
TNF-α (log)  -2.58 (2.83)  0.363 
TNF-α (log)*age  -0.54 (0.44)  0.227 
TNF-α (log)*sex  -7.25 (5.73)  0.206 
     
IL-6 (log)  -8.06 (20.3)  0.691 
IL-6 (log)*age  -2.15 (2.47)  0.385 
IL-6 (log)*sex4  84.7 (38.5)  0.028 

































    Beta (SE)  p1 
       
Leptin (log)1  - 38.0 (18.4)  0.039 
Adjusted also for:        IL-6   -37.5 (18.7)  0.045 
                                    CRP  -35.1 (19.2)  0.068 
    
CRP (log)*sex1  70.0 (30.1)  0.020 
Adjusted also for:        IL-6        71.1 (30.2)  0.019 
                                  Leptin  76.0 (31.1)  0.015 
    
IL-6 (log)*sex1  84.7 (38.5)  0.028 
Adjusted also for:        CRP  81.1 (38.6)  0.036 
                                  Leptin  78.6 (39.2)  0.045 






















 This study sought to examine whether concentrations of leptin, ghrelin and 
inflammatory markers were associated with accelerated decline in energy intake in 
older persons living in the community. We found that a higher concentration of leptin 
was significantly associated with accelerated decline in energy intake during three 
years of follow-up. After adjustment for CRP, this relationship was marginally 
significant. Furthermore, we found a significant interaction between CRP and IL-6 and 
Leptin (Log, ng/mL) at Baseline

































































Figure 5. Relationship between Leptin (at Baseline) and Energy Intake (at Follow-up) 
* After adjustment for age, sex, energy intake at baseline, number of diseases 
  Area in yellow indicates accelerated decline in energy intake   
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sex on change in energy intake. In men, a high concentration of both CRP and IL-6 
was associated with greater decline in energy intake compared to women, independent 
of the presence of diseases. These findings are in line with previous studies suggesting 
that leptin plays a role in the long-term regulation of energy homeostasis, including 
energy intake (Horwitz B 2002), and that increased concentration of inflammatory 
markers may contribute to anorexia of aging (MacIntosh 2000). Leptin crosses the 
blood-brain barrier to bind receptors, and leptin receptors are expressed by brain 
neurons involved in regulating energy intake (Cheng CC 1997). One of the 
mechanisms by which leptin inhibits energy intake is by altering the transcription of 
hypothalamic neuropeptides, for example downregulating the orexigenic neuropeptide 
Y and upregulating the anorexigenic alpha-melanocyte-stimulating hormone (Jequier 
E 2002). 
IL-6 is the major cytokine regulating the hepatic production of CRP (Heinrich 
PC 1990). Receptors for interleukin-6 and for leptin are present on hepatic cells and 
have similar action (Wang Y 1997), suggesting that leptin may stimulate the 
production of CRP. This hypothesis has been demonstrated in isolated human 
hepatocytes (Dowidar NL 2000), and accordingly we have previously found a 
significant association between leptin and CRP independent of IL-6 (Ble A 2006). On 
the other hand, it has been suggested that cytokines produce their anorectic effects by 
stimulating the leptin receptors (Zhang F, 1997). Thus, a complex interplay may exist 
between leptin and IL-6 and CRP. Our results, however, provide evidence that high 
concentration of leptin affects energy intake independent of the levels of CRP and IL-
6. Ghrelin was not associated with consequent change in energy intake. This result is 
in line with previous studies suggesting that ghrelin is mainly involved in short-term 
regulation of food control (pre- and postprandial) while leptin is mainly involved in 
the long-term regulation (Di Francesco 2006; Wynne K 2005). 
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A limitation of the study is that we measured total ghrelin concentration 
whereas it has been suggested that acylated ghrelin, the active form of ghrelin, is a 
more accurate measure (Akamizu T 2005). Thus, further studies using acylated ghrelin 
are needed to confirm our findings. An important strength of this study is the nature of 
its design. Longitudinal research is particularly useful to study etiology (Tooth L 
2005), which was the purpose of this study. Furthermore, we used a population-based 
sample of older persons living in the community. Consequently, our findings can be 
generalized to the general older population. To our knowledge, this is the first 
longitudinal study on the effect of leptin, ghrelin, and inflammatory markers on 
change in energy intake using a population-based sample of older persons living in the 
community. 
In conclusion, we found that a high concentration of leptin was significantly 
associated with an accelerated decline in energy intake in older persons living in the 
community. Furthermore, high concentrations of both CRP and IL-6 were associated 
with greater decline in energy intake in men compared with women. Further studies 
are needed to understand the complex mechanisms underlying anorexia of aging. 
These results may help to understand, at list in part, the etiology of this phenomena, 
and ultimately inform the development of screening and intervention strategies aimed 
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This study sought to examine whether poor nutrition plays a role in declining in 
muscle strength and physical function in older persons, and whether concentrations of 
ghrelin, leptin and inflammatory markers are associated with reduction in dietary 
intake. In particular, three hypotheses were tested: 1) a low intake of protein is 
associated with subsequent reduction in muscle strength (sarcopenia) and the effect of 
protein intake on muscle strength depends on concentrations of markers of 
inflammation; 2) a low concentration of nutrients is associated with subsequent 
decline in physical function; 3) concentrations of ghrelin, leptin and inflammatory 
markers are associated with reduced dietary intake.  
These results demonstrated that protein intake is not associated overall with 
increased muscle strength in older persons. We found, however, that in older persons 
with high levels of inflammatory markers, lower protein intake was associated with a 
greater decline in muscle strength, and a low concentration of vitamin E was 
associated with subsequent decline in physical function. Furthermore, high 
concentrations of leptin and inflammatory markers predicted accelerated decline in 
dietary intake. 
This is the first population-based, longitudinal study on the effect of poor 
nutrition on decline in muscle strength and physical function, and on the effect of 
ghrelin, leptin and inflammatory markers on anorexia of aging. This pioneer study 
provides empirical evidence that poor nutrition plays an important role in the decline 
in muscle strength and physical function in older persons and, consequently, may 
contribute to the disablement process. Furthermore, increased concentrations of leptin 
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and inflammatory markers may explain, at least in part, the exacerbation of anorexia 
of aging and, consequently, poor nutrition in older persons.  
Further studies are needed to evaluate whether and to what extent sarcopenia 
mediates the relationship between undernutrition and subsequent decline in physical 
function, and to understand the complex biological mechanisms underlying the decline 
in muscle strength, in physical function and anorexia of aging. These findings, 
however, may help to understand the etiology of sarcopenia and the reduction of 
physical function, and to identify the physiological factors contributing to poor 
nutrition in this particular segment of the population.  
With the identified factors (leptin, inflammatory markers, age), it may be 
possible to target older persons who are at risk of undernutrition and/or nutrition-
related decline in muscle strength and in physical function and, consequently, those 
who could benefit from nutritional intervention. In particular, older persons with high 
concentrations of leptin and inflammatory markers may be at risk of decline in dietary 
intake. Although protein intake does not have an overall effect on muscle strength in 
older persons, we identified the segment of the older population in which a low protein 
intake may have a detrimental effect on muscle strength.  Selectively in persons with 
high levels of inflammatory markers, a low intake of protein was associated with 
subsequent decline in physical function. Furthermore, the study on the relationship 
between levels of nutrients and physical function showed that a low concentration of 
vitamin E is associated with subsequent decline in physical function. In particular, we 
identified the segment of the older population in which a low concentration of vitamin 
E is associated with subsequent decline in physical function. In fact, we found that 
participants at highest and lowest risk of decline in physical function independent 
were those aged > 80 and < 70 years, respectively, and low levels of vitamin E was the 
strongest predictor of decline in physical function in participants aged from 70 to 80 
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years old. Using the cut-off of vitamin E defined by the regression tree analyses (32 
mcg/ml), we found that the sensitivity for this test was 61%. This suggests that a 
screening test to identify older persons who are at risk of decline in physical function 
cannot be based only on age and levels of vitamin E. This study, however, identified 
the age-group (from 70 to 80 years old) in which older persons are more vulnerable to 
decline in physical function and may benefit from nutritional intervention. Thus, this 
study has important implications for the development of screening and intervention 
strategies aimed at preventing poor nutrition and reducing the decline in muscle 
strength and physical function with aging. Finally, these results may help to 
understand the disablement process and to prevent its detrimental consequences, 


























Protein (g/day) 77.5 20.5 76.3 26.9 133.7 62.5 89.5 
CRP (mg/L) 3.98 5.06 2.35 3.57 47.85 1.23 4.80 
IL-6 (pg/ml) 1.86 3.60 1.28 1.15 77.99 0.75 1.9 
TNF-α (pg/ml) 3.38 4.82 1.90 1.52 38.8 1.44 2.96 
Chapter 3 
Vit E (µmol/L) 30.2 8.35 29.13 10.50 76.89 24.40 34.90 
Vit B12 (pg/mL) 458 345 370 225 1945 275 500 
Vit B6 (ng/mL) 7.01 6.47 5.88 4.27 91.7 4.06 8.33 
Fol Ac(ng/mL) 3.24 1.93 2.80 2.10 19.70 2.0 4.1 
Vit D (nmol/L) 52.0 36.8 303 39.2 303.5 28.3 67.5 
Iron (µg/dL) 84.3 25.3 83 32 181 67 99  
Chapter 4 
Ghrelin 0.28 0.06 0.28 0.078 0.078 0.24 0.32 
Leptin 13.37 17.1 8.24 12.4 257 4.03 16.4 
CRP (mg/L) 4.82 7.73 2.67 4.12 110 1.27 5.42 
IL-6 (pg/mL) 2.11 3.53 1.40 1.28 77.98 0.84 2.12 
TNF-α (pg/mL) 3.75 5.61 1.98 1.72 38.8 1.49 3.21 
